Application of the IFN-γ ELISPOT assay to quantify T cell responses against proteins

被引：58

作者：

Schmittel, A

Keilholz, U

Bauer, S

Kuhne, U

Stevanovic, S

Thiel, E

Scheibenbogen, C

机构：

[1] Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 3, D-12200 Berlin, Germany

[2] Univ Tubingen, Inst Zelibiol, Immunol Abt, D-72076 Tubingen, Germany

来源：

JOURNAL OF IMMUNOLOGICAL METHODS | 2001年 / 247卷 / 1-2期

关键词：

ELISPOT; T cells; protein; tetanus toxoid; purified protein derivative; influenza matrix protein;

D O I：

10.1016/S0022-1759(00)00305-7

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The ELISPOT assay has been established for the direct ex vivo quantification of peptide-reactive T lymphocytes from peripheral blood mononuclear cells (PBMC). In this report we studied the ELISPOT assay conditions for the detection of T cell responses against protein antigens including Tetanus toroid (TT), purified-protein-derivative (PPD) and a synthetic 30 mer peptide derived from influenza matrix protein (IMP) containing the HLA-A*0201-restricted 9 mer peptide epitope GILGFVFTL as a model for a viral protein. We found several aspects to be crucial for a sensitive detection of T cell responses against proteins including a pellet preincubation step and the monocyte concentration. Using optimized assay conditions specific CD4+ T cell responses against TT and PPD as well as CD8+ T cell responses against IMP can be quantified directly ex vivo from peripheral blood mononuclear cells. (C) 2001 Elsevier Science B.V. All rights reserved.

引用

页码：17 / 24

页数：8

共 20 条

[1] BEDNAREK MA, 1991, J IMMUNOL, V147, P4047
[2] USE OF MONOCLONAL-ANTIBODIES AS SENSITIVE AND SPECIFIC PROBES FOR BIOLOGICALLY-ACTIVE HUMAN GAMMA-INTERFERON
CHANG, TW
MCKINNEY, S
LIU, V
KUNG, PC
VILCEK, J
LE, JM
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (16): : 5219 - 5222
[3] REVERSE ELISPOT ASSAY FOR CLONAL ANALYSIS OF CYTOKINE PRODUCTION .1. ENUMERATION OF GAMMA-INTERFERON-SECRETING CELLS
CZERKINSKY, C
ANDERSSON, G
EKRE, HP
NILSSON, LA
KLARESKOG, L
OUCHTERLONY, O
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 110 (01) : 29 - 36
[4] The use of computer-assisted video image analysis for the quantification of CD8(+) T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens
Herr, W
Linn, B
Leister, N
Wandel, E
zumBuschenfelde, KHM
Wolfel, T
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 203 (02) : 141 - 152
[5] Detection and quantification of blood-derived CD8(+) T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens
Herr, W
Schneider, J
Lohse, AW
zumBuschenfelde, KHM
Wolfel, T
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 191 (02) : 131 - 142
[6] INOUE M, 1989, J IMMUNOL, V142, P4006
[7] EFFICIENT MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PRESENTATION OF EXOGENOUS ANTIGEN UPON PHAGOCYTOSIS BY MACROPHAGES
KOVACSOVICSBANKOWSKI, M
CLARK, K
BENACERRAF, B
ROCK, KL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) : 4942 - 4946
[8] Luckey CJ, 1998, J IMMUNOL, V161, P112
[9] Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
Nestle, FO
Alijagic, S
Gilliet, M
Sun, YS
Grabbe, S
Dummer, R
Burg, G
Schadendorf, D
[J]. NATURE MEDICINE, 1998, 4 (03) : 328 - 332
[10] Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses
Österborg, A
Yi, Q
Henriksson, L
Fagerberg, J
Bergenbrant, S
Jeddi-Tehrani, M
Rudén, U
Lefvert, AK
Holm, G
Mellstedt, H
[J]. BLOOD, 1998, 91 (07) : 2459 - 2466

← 1 2 →